At AgeWell Medicine & Aesthetics, we prioritize patient safety and ethical practice, offering only those therapies supported by clinical science and compliant with current regulations
Treatment should only continue if there is a reduction in HbA1c of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight after 6 months
Check our Is Zepbound Covered by Insurance
The Science Behind Combination Therapy BPC-157 and IGF-1 work through different pathways, making them highly compatible for combination use
[DOI] [PubMed] [Google Scholar] 47.Bossart M., Wagner M., Elvert R., Evers A., Hubschle T., Kloeckener T., Lorenz K., Moessinger C., Eriksson O., Velikyan I., et al
Dan HC, Ebbs A, Pasparakis M, Van Dyke T, Basseres DS, Baldwin AS